Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lisa H Butterfield

Showing results (151-160 of 167) with videos related to

Pageof 17
Sort By:
Cancer|December 2, 2016
Immunotherapy of head and neck cancer: Emerging clinical trials from a National Cancer Institute Head and Neck Cancer Steering Committee Planning MeetingJulie E Bauman, Ezra Cohen, Robert L Ferris, et al.
Cancer Immunology Research|April 1, 2022
Hallmarks of Resistance to Immune-Checkpoint InhibitorsMaria Karasarides, Alexandria P Cogdill, Paul B Robbins, et al.
Cancer Prevention Research (Philadelphia, Pa.)|April 26, 2018
Evaluation of Biodistribution of Sulforaphane after Administration of Oral Broccoli Sprout Extract in Melanoma Patients with Multiple Atypical NeviShawn Tahata, Shivendra V Singh, Yan Lin, et al.
The Journal of Clinical Investigation|August 21, 2020
Mass cytometry detects H3.3K27M-specific vaccine responses in diffuse midline gliomaSabine Mueller, Jared M Taitt, Javier E Villanueva-Meyer, et al.
The Lancet. Oncology|October 10, 2017
Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trialHussein A Tawbi, Melissa Burgess, Vanessa Bolejack, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 23, 2021
Neoadjuvant Pembrolizumab and High-Dose IFNα-2b in Resectable Regionally Advanced MelanomaYana G Najjar, Dustin McCurry, Huang Lin, et al.
Journal for Immunotherapy of Cancer|November 17, 2020
Defining best practices for tissue procurement in immuno-oncology clinical trials: consensus statement from the Society for Immunotherapy of Cancer Surgery CommitteeBrian Gastman, Piyush K Agarwal, Adam Berger, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 12, 2011
Recommendations from the iSBTc-SITC/FDA/NCI Workshop on Immunotherapy BiomarkersLisa H Butterfield, A Karolina Palucka, Cedrik M Britten, et al.
Journal of Translational Medicine|December 25, 2008
A systematic approach to biomarker discovery; preamble to "the iSBTc-FDA taskforce on immunotherapy biomarkers"Lisa H Butterfield, Mary L Disis, Bernard A Fox, et al.
Nature Medicine|June 6, 2022
Sotigalimab and/or nivolumab with chemotherapy in first-line metastatic pancreatic cancer: clinical and immunologic analyses from the randomized phase 2 PRINCE trialLacey J Padrón, Deena M Maurer, Mark H O'Hara, et al.
Pageof 17

Showing results (151-160 of 167) with videos related to

Sort By:
Pageof 17
Cancer|December 2, 2016
Immunotherapy of head and neck cancer: Emerging clinical trials from a National Cancer Institute Head and Neck Cancer Steering Committee Planning MeetingJulie E Bauman, Ezra Cohen, Robert L Ferris, et al.
Cancer Immunology Research|April 1, 2022
Hallmarks of Resistance to Immune-Checkpoint InhibitorsMaria Karasarides, Alexandria P Cogdill, Paul B Robbins, et al.
Cancer Prevention Research (Philadelphia, Pa.)|April 26, 2018
Evaluation of Biodistribution of Sulforaphane after Administration of Oral Broccoli Sprout Extract in Melanoma Patients with Multiple Atypical NeviShawn Tahata, Shivendra V Singh, Yan Lin, et al.
The Journal of Clinical Investigation|August 21, 2020
Mass cytometry detects H3.3K27M-specific vaccine responses in diffuse midline gliomaSabine Mueller, Jared M Taitt, Javier E Villanueva-Meyer, et al.
The Lancet. Oncology|October 10, 2017
Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trialHussein A Tawbi, Melissa Burgess, Vanessa Bolejack, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 23, 2021
Neoadjuvant Pembrolizumab and High-Dose IFNα-2b in Resectable Regionally Advanced MelanomaYana G Najjar, Dustin McCurry, Huang Lin, et al.
Journal for Immunotherapy of Cancer|November 17, 2020
Defining best practices for tissue procurement in immuno-oncology clinical trials: consensus statement from the Society for Immunotherapy of Cancer Surgery CommitteeBrian Gastman, Piyush K Agarwal, Adam Berger, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 12, 2011
Recommendations from the iSBTc-SITC/FDA/NCI Workshop on Immunotherapy BiomarkersLisa H Butterfield, A Karolina Palucka, Cedrik M Britten, et al.
Journal of Translational Medicine|December 25, 2008
A systematic approach to biomarker discovery; preamble to "the iSBTc-FDA taskforce on immunotherapy biomarkers"Lisa H Butterfield, Mary L Disis, Bernard A Fox, et al.
Nature Medicine|June 6, 2022
Sotigalimab and/or nivolumab with chemotherapy in first-line metastatic pancreatic cancer: clinical and immunologic analyses from the randomized phase 2 PRINCE trialLacey J Padrón, Deena M Maurer, Mark H O'Hara, et al.
Pageof 17